This inventor holds 1 USPTO granted patent and 3 EPO patents. Top assignees: Catalent France Beinheim Sa, Endotis Pharma. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Julien Meissonnier
Introduction
Julien Meissonnier is a notable inventor based in La Wantzenau, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His innovative approach has led to the creation of a unique pharmaceutical formulation that incorporates synthetic oligosaccharides.
Latest Patents
Julien Meissonnier holds 1 patent for his invention titled "Pharmaceutical oral dosage form containing a synthetic oligosaccharide." This patent describes a pharmaceutical formulation intended for oral administration that includes a synthetic oligosaccharide with therapeutic activity. The formulation is designed to optimize the delivery and efficacy of the active ingredients, making it a valuable contribution to the pharmaceutical industry.
Career Highlights
Throughout his career, Julien Meissonnier has worked with several prominent companies, including Catalent France Beinheim and Endotis Pharma. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects in the pharmaceutical sector.
Collaborations
Julien has collaborated with notable professionals in his field, including Nathalie Sicre and Guy Dubreucq. These collaborations have further enhanced his work and contributed to the advancement of pharmaceutical formulations.
Conclusion
Julien Meissonnier's innovative work in pharmaceutical formulations showcases his dedication to improving healthcare solutions. His contributions, particularly in the area of synthetic oligosaccharides, highlight the importance of innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile